Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$11.1M
1 round on record
Latest round
$11.1M
Venture round · May 2020 · 6 yr ago
Team
51-200
employees, estimated range
Backers
1
Xontogeny
The money's age
Long since its last round
76 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 22, 2020 Raised a round Venture round $11.1M · SEC Form D 2020 Founded
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2020 $11.1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity CereVasc, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Aaron LevangieExecutive OfficerSEC Form D
Daniel LevangieExecutive Officer, DirectorSEC Form D
Leslie Teso-LichtmanExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
The Zeiko document, a new way of communicating. Extremely simple, incredibly effective.
StimCardio11-50 employees
StimCardio delivers innovative cardiac stimulation solutions designed to improve patient outcomes, support clinicians, and advance the…
Support every patient and extend every team to improve patient outcomes, grow revenues, and reduce costs. Nora, our agentic operating layer…
Zynix.AIFounded 2024 • 51-200 employees • 2 roles
Zynix AI is a healthcare-focused technology company that provides advanced AI-powered solutions to help healthcare institutions streamline…
Vera HealthFounded 2024 • 201-500 employees • 10 roles
Improve patient outcomes with evidence-based answers from 60M+ peer-reviewed medical papers. Built by clinicians and AI researchers.
AidinFounded 2023 • 1-10 employees • 3 roles
Aidin's healthcare referral management software improves patient outcomes & eliminates costly delays within one seamless digital platform.

Overview

The CereVasc eShunt® device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus.

People

Aaron Levangie
Executive Officer
Daniel Levangie
Executive Officer, Director
Leslie Teso-Lichtman
Executive Officer
Frederick Callori
Director
Chris Garabedian
Director
Patrick Sullivan
Director
Carl Heilman
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Auburndale United States
HQ
50-200 est. staff

Financials

Total raised
$11.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2020 $11.1M Details